Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Super-resolution track density imaging of glioblastoma: histopathologic correlation.

Barajas RF Jr, Hess CP, Phillips JJ, Von Morze CJ, Yu JP, Chang SM, Nelson SJ, McDermott MW, Berger MS, Cha S.

AJNR Am J Neuroradiol. 2013 Jul;34(7):1319-25. doi: 10.3174/ajnr.A3400. Epub 2013 Feb 14.

2.

Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging.

Barajas RF Jr, Phillips JJ, Parvataneni R, Molinaro A, Essock-Burns E, Bourne G, Parsa AT, Aghi MK, McDermott MW, Berger MS, Cha S, Chang SM, Nelson SJ.

Neuro Oncol. 2012 Jul;14(7):942-54. doi: 10.1093/neuonc/nos128. Epub 2012 Jun 18.

3.

Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging.

Barajas RF Jr, Hodgson JG, Chang JS, Vandenberg SR, Yeh RF, Parsa AT, McDermott MW, Berger MS, Dillon WP, Cha S.

Radiology. 2010 Feb;254(2):564-76. doi: 10.1148/radiol.09090663.

4.
5.

Track-density imaging (TDI): super-resolution white matter imaging using whole-brain track-density mapping.

Calamante F, Tournier JD, Jackson GD, Connelly A.

Neuroimage. 2010 Dec;53(4):1233-43. doi: 10.1016/j.neuroimage.2010.07.024. Epub 2010 Jul 17.

PMID:
20643215
6.

Super-resolution track-density imaging studies of mouse brain: comparison to histology.

Calamante F, Tournier JD, Kurniawan ND, Yang Z, Gyengesi E, Galloway GJ, Reutens DC, Connelly A.

Neuroimage. 2012 Jan 2;59(1):286-96. doi: 10.1016/j.neuroimage.2011.07.014. Epub 2011 Jul 14.

PMID:
21777683
7.

Visualization of mouse barrel cortex using ex-vivo track density imaging.

Kurniawan ND, Richards KL, Yang Z, She D, Ullmann JF, Moldrich RX, Liu S, Yaksic JU, Leanage G, Kharatishvili I, Wimmer V, Calamante F, Galloway GJ, Petrou S, Reutens DC.

Neuroimage. 2014 Feb 15;87:465-75. doi: 10.1016/j.neuroimage.2013.09.030. Epub 2013 Sep 21.

PMID:
24060319
8.

Computer-aided detection of brain tumor invasion using multiparametric MRI.

Jensen TR, Schmainda KM.

J Magn Reson Imaging. 2009 Sep;30(3):481-9. doi: 10.1002/jmri.21878.

9.

Glioblastoma multiforme versus solitary supratentorial brain metastasis: differentiation based on morphology and magnetic resonance signal characteristics.

Maurer MH, Synowitz M, Badakshi H, Lohkamp LN, Wüstefeld J, Schäfer ML, Wiener E.

Rofo. 2013 Mar;185(3):235-40. doi: 10.1055/s-0032-1330318. Epub 2012 Nov 29.

10.

Comparison of DSC-MRI post-processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBM.

Essock-Burns E, Phillips JJ, Molinaro AM, Lupo JM, Cha S, Chang SM, Nelson SJ.

J Magn Reson Imaging. 2013 Aug;38(2):388-400. doi: 10.1002/jmri.23982. Epub 2012 Dec 19.

11.

Effects of dexamethasone on cerebral perfusion and water diffusion in patients with high-grade glioma.

Bastin ME, Carpenter TK, Armitage PA, Sinha S, Wardlaw JM, Whittle IR.

AJNR Am J Neuroradiol. 2006 Feb;27(2):402-8.

12.

Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: an image-guided biopsy study.

Price SJ, Jena R, Burnet NG, Hutchinson PJ, Dean AF, Peña A, Pickard JD, Carpenter TA, Gillard JH.

AJNR Am J Neuroradiol. 2006 Oct;27(9):1969-74.

13.

Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.

Doskaliyev A, Yamasaki F, Ohtaki M, Kajiwara Y, Takeshima Y, Watanabe Y, Takayasu T, Amatya VJ, Akiyama Y, Sugiyama K, Kurisu K.

Eur J Radiol. 2012 Feb;81(2):339-44. doi: 10.1016/j.ejrad.2010.11.005. Epub 2010 Dec 3.

PMID:
21129872
14.

Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.

Gevaert O, Mitchell LA, Achrol AS, Xu J, Echegaray S, Steinberg GK, Cheshier SH, Napel S, Zaharchuk G, Plevritis SK.

Radiology. 2014 Oct;273(1):168-74. doi: 10.1148/radiol.14131731. Epub 2014 May 12. Erratum in: Radiology. 2015 Jul;276(1):313.

15.

Quantification of track-weighted imaging (TWI): characterisation of within-subject reproducibility and between-subject variability.

Willats L, Raffelt D, Smith RE, Tournier JD, Connelly A, Calamante F.

Neuroimage. 2014 Feb 15;87:18-31. doi: 10.1016/j.neuroimage.2013.11.016. Epub 2013 Nov 16.

PMID:
24246491
16.

Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.

Calli C, Kitis O, Yunten N, Yurtseven T, Islekel S, Akalin T.

Eur J Radiol. 2006 Jun;58(3):394-403. Epub 2006 Mar 9.

PMID:
16527438
17.

Comparative evaluation of dynamic contrast-enhanced perfusion with diffusion tensor imaging metrics in assessment of corticospinal tract infiltration in malignant glioma.

Awasthi R, Verma SK, Haris M, Singh A, Behari S, Jaiswal AK, Rajput D, Pandey R, Rathore RK, Pandey CM, Gupta RK.

J Comput Assist Tomogr. 2010 Jan;34(1):82-8. doi: 10.1097/RCT.0b013e3181ae29f0.

PMID:
20118727
18.

Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging.

Provenzale JM, McGraw P, Mhatre P, Guo AC, Delong D.

Radiology. 2004 Aug;232(2):451-60. Epub 2004 Jun 23.

PMID:
15215555
19.

Cell invasion, motility, and proliferation level estimate (CIMPLE) maps derived from serial diffusion MR images in recurrent glioblastoma treated with bevacizumab.

Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Pope WB.

J Neurooncol. 2011 Oct;105(1):91-101. doi: 10.1007/s11060-011-0567-8. Epub 2011 Mar 26.

PMID:
21442275
20.

Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].

Lev MH, Ozsunar Y, Henson JW, Rasheed AA, Barest GD, Harsh GR 4th, Fitzek MM, Chiocca EA, Rabinov JD, Csavoy AN, Rosen BR, Hochberg FH, Schaefer PW, Gonzalez RG.

AJNR Am J Neuroradiol. 2004 Feb;25(2):214-21. Erratum in: AJNR Am J Neuroradiol. 2004 Mar;25(3):B1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk